輝瑞藥廠(Pfizer)與新冠疫苗研發夥伴德國BioNTech藥廠8日上午發表聲明指出，已經完成接種兩劑輝瑞疫苗的民眾，如果再打俗稱補強針的第三劑，身體當中的抗體指數將大幅提高，有助於抵抗Omicron變種病毒，進而達到降低Omicron傳播的目的
Past 31 days
Total Visit: 0
No response has been written yet. It is recommended to maintain a healthy skepticism towards it.
查謠言詐騙